Skip to main content

Chronopharmacology and its implications to the pharmacology of sleep

  • Chapter
  • 1760 Accesses

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Buijs RM, Van Eden CG, Goncharuk VD, Kalsbeek A (2003) The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol 177: 17–26

    Article  PubMed  CAS  Google Scholar 

  2. Hastings MH, Reddy AB, Maywood ES (2003) A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 4: 649–661

    Article  PubMed  CAS  Google Scholar 

  3. Gachon F, Nagoshi E, Brown SA, Ripperger J, Schibler U (2004) The mammalian circadian timing system: from gene expression to physiology. Chromosoma 113: 103–112

    Article  PubMed  Google Scholar 

  4. Smolensky MH, Haus E (2001) Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens 14: 280S–290S

    Article  PubMed  CAS  Google Scholar 

  5. Cermakian N, Boivin DB (2003) A molecular perspective of human circadian rhythm disorders. Brain Res Brain Res Rev 42: 204–220

    Article  PubMed  CAS  Google Scholar 

  6. Folkard S, Tucker P (2003) Shift work, safety and productivity. Occup Med (Lond) 53: 95–101

    Article  Google Scholar 

  7. Knutsson A, Boggild H (2000) Shiftwork and cardiovascular disease: review of disease mechanisms. Rev Environ Health 15: 359–372

    PubMed  CAS  Google Scholar 

  8. Desai VG, Moland CL, Branham WS, Delongchamp RR, Fang H, Duffy PH, Peterson CA, Beggs ML, Fuscoe JC (2004) Changes in expression level of genes as a function of time of day in the liver of rats. Mutat Res 549: 115–129

    PubMed  CAS  Google Scholar 

  9. Arkinstall WW (1988) Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma. Am J Med 85: 60–63

    Article  PubMed  CAS  Google Scholar 

  10. Martin RJ, Banks-Schlegel S (1998) Chronobiology of asthma. Am J Respir Crit Care Med 158: 1002–1007

    PubMed  CAS  Google Scholar 

  11. Kraft M, Martin RJ (1995) Chronobiology and chronotherapy in medicine. Dis Mon 41: 501–575

    PubMed  CAS  Google Scholar 

  12. Auvil-Novak SE (1999) The chronobiology, chronopharmacology, and chronotherapeutics of pain. Annu Rev Nurs Res 17: 133–153

    PubMed  CAS  Google Scholar 

  13. Vener KJ, Reddy A (1992) Timed treatment of the arthritic diseases: a review and hypothesis. Semin Arthritis Rheum 22: 83–97

    Article  PubMed  CAS  Google Scholar 

  14. Zabielski R (2004) Reefs in experimental gastroenterology-cyclic activities of the gastrointestinal tract. J Physiol Pharmacol 55,Suppl 2: 19–32

    PubMed  Google Scholar 

  15. Pan X, Terada T, Okuda M, Inui K (2004) The diurnal rhythm of the intestinal transporters SGLT1 and PEPT1 is regulated by the feeding conditions in rats. J Nutr 134: 2211–2215

    PubMed  CAS  Google Scholar 

  16. Moore JG, Englert E Jr. (1970) Circadian rhythm of gastric acid secretion in man. Nature 226: 1261–1262

    Article  PubMed  CAS  Google Scholar 

  17. Cloud ML, Offen WW (1992) Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group. Dig Dis Sci 37: 865–874

    Article  PubMed  CAS  Google Scholar 

  18. Sanders SW, Moore JG (1992) Gastrointestinal chronopharmacology: physiology, pharmacology and therapeutic implications. Pharmacol Ther 54: 1–15

    Article  PubMed  CAS  Google Scholar 

  19. Humphries TJ, Root JK, Hufnagel K (1991) Successful drug-specific chronotherapy with the H2 blocker famotidine in the symptomatic relief of gastroesophageal reflux disease. Ann N Y Acad Sci 618: 517

    PubMed  CAS  Google Scholar 

  20. Pounder RE (1991) Degrees of acid suppression and ulcer healing: dosage considerations. Aliment Pharmacol Ther 5,Suppl 1: 5–13

    PubMed  Google Scholar 

  21. Hassler C, Burnier M (2005) Circadian variations in blood pressure: implications for chronotherapeutics. Am J Cardiovasc Drugs 5: 7–15

    Article  PubMed  Google Scholar 

  22. Perez-Lloret S, Aguirre AG, Cardinali DP, Toblli JE (2004) Disruption of ultradian and circadian rhythms of blood pressure in nondipper hypertensive patients. Hypertension 44: 311–315

    Article  PubMed  CAS  Google Scholar 

  23. Trotti R, Rondanelli M, Cuzzoni G, Ferrari E, d’Eril GM (2002) Circadian temporal organization of lipidic fractions in elderly people. Entrainment to the dietary schedule. Aging Clin Exp Res 14: 94–99

    PubMed  Google Scholar 

  24. Stein EA, Davidson MH, Dobs AS, Schrott H, Dujovne CA, Bays H, Weiss SR, Melino MR, Stepanavage ME, Mitchel YB (1998) Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. Am J Cardiol 82: 311–316

    Article  PubMed  CAS  Google Scholar 

  25. Renko AK, Hiltunen L, Laakso M, Rajala U, Keinanen-Kiukaanniemi S (2005) The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract 67: 84–91

    Article  PubMed  CAS  Google Scholar 

  26. Hrushesky W, Wood P, Levi F, von Roemeling R, Bjarnason G, Focan C, Meier K, Cornelissen G, Halberg F (2004) A recent illustration of some essentials of circadian chronotherapy study design. J Clin Oncol 22: 2971–2972

    Article  PubMed  Google Scholar 

  27. Levi F (2001) Circadian chronotherapy for human cancers. Lancet Oncol 2: 307–315

    Article  PubMed  CAS  Google Scholar 

  28. Nagayama H, Cornelissen G, Pandi-Perumal SR, Halberg F (2005) Time-dependence psychotropic drug effects: hints of pharmacochronomics, broader than circadian time structures. In: M Lader, DP Cardinali, SR Pandi-Perumal (eds): Sleep and Sleep Disorders: A neuropharmacological Approach. Landes Biosciences, Georgetown, 34–71

    Google Scholar 

  29. Pace-Schott EF, Hobson JA (2002) The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3: 591–605

    PubMed  CAS  Google Scholar 

  30. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59: 131–136

    Article  PubMed  Google Scholar 

  31. Anderson IM (2001) Meta-analytical studies on new antidepressants. Br Med Bull 57: 161–178

    Article  PubMed  CAS  Google Scholar 

  32. Nagayama H, Nagano K, Ikezaki A, Tashiro T (1991) Double-blind study of the chronopharmacotherapy of depression. Chronobiol Int 8: 203–209

    PubMed  CAS  Google Scholar 

  33. Harvey BH, Bouwer CD (2000) Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors. Clin Neuropharmacol 23: 90–97

    Article  PubMed  CAS  Google Scholar 

  34. Dawson D, Armstrong SM (1996) Chronobiotics-drugs that shift rhythms. Pharmacol Ther 69: 15–36

    Article  PubMed  CAS  Google Scholar 

  35. Cardinali DP, Pévet P (1998) Basic aspects of melatonin action. Sleep Med Rev 2: 175–190

    Article  PubMed  CAS  Google Scholar 

  36. Lewy AJ, Bauer VK, Ahmed S, Thomas KH, Cutler NL, Singer CM, Moffit MT, Sack RL (1998) The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol Int 15: 71–83

    Article  PubMed  CAS  Google Scholar 

  37. Kennaway DJ, Wright H (2002) Melatonin and circadian rhythms. Curr Top Med Chem 2: 199–209

    Article  PubMed  CAS  Google Scholar 

  38. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI (2003) Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8: D1093–D1108

    PubMed  CAS  Google Scholar 

  39. Lavie P (2001) Sleep-wake as a biological rhythm. Annu Rev Psychol 52: 277–303

    Article  PubMed  CAS  Google Scholar 

  40. Buysse DJ, Nofzinger EA, Germain A, Meltzer CC, Wood A, Ombao H, Kupfer DJ, Moore RY (2004) Regional brain glucose metabolism during morning and evening wakefulness in humans: preliminary findings. Sleep 27: 1245–1254

    PubMed  Google Scholar 

  41. Hirai K, Kita M, Ohta H, Nishikawa H, Fujiwara Y, Ohkawa S, Miyamoto M (2005) Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats. J Biol Rhythms 20: 27–37

    Article  PubMed  CAS  Google Scholar 

  42. Skene DJ, Lockley SW, Arendt J (1999) Melatonin in circadian sleep disorders in the blind. Biol Signals Recept 8: 90–95

    Article  PubMed  CAS  Google Scholar 

  43. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9: 41–50

    Article  PubMed  Google Scholar 

  44. Cardinali DP, Brusco LI, Liberczuk C, Furio AM (2002) The use of melatonin in Alzheimer’s disease. Neuroendocrinol Lett 23(Suppl. 1): 20–23

    PubMed  CAS  Google Scholar 

  45. Herxheimer A, Petrie KJ (2002) Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev CD001520

    Google Scholar 

  46. Cardinali DP, Bortman GP, Liotta G, Perez LS, Albornoz LE, Cutrera RA, Batista J, Ortega GP (2002) Amultifactorial approach employing melatonin to accelerate resynchronization of sleep-wake cycle after a 12 time-zone westerly transmeridian flight in elite soccer athletes. J Pineal Res 32: 41–46

    Article  PubMed  CAS  Google Scholar 

  47. Cardinali DP, Furio AM, Reyes MP, Brusco LI (2005) The use of chronobiotics in the resynchronization of the sleep/wake cycle. Cancer Causes & Contro, in press

    Google Scholar 

  48. Mishima K, Tozawa T, Satoh K, Matsumoto Y, Hishikawa Y, Okawa M (1999) Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biol Psychiatry 45: 417–421

    Article  PubMed  CAS  Google Scholar 

  49. Zhou JN, Liu RY, Kamphorst W, Hofman MA, Swaab DF (2003) Early neuropathological Alzheimer’s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 35: 125–130

    Article  PubMed  CAS  Google Scholar 

  50. Skene DJ, Swaab DF (2003) Melatonin rhythmicity: effect of age and Alzheimer’s disease. Exp Gerontol 38: 199–206

    Article  PubMed  CAS  Google Scholar 

  51. Fainstein I, Bonetto A, Brusco LI, Cardinali DP (1997) Effects of melatonin in elderly patients with sleep disturbance. A pilot study. Curr Ther Res 58: 990–1000

    Article  CAS  Google Scholar 

  52. Jean-Louis G, von Gizycki H, Zizi F (1998) Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 25: 177–183

    PubMed  CAS  Google Scholar 

  53. Brusco LI, Marquez M, Cardinali DP (1998) Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer’s disease. Neuroendocrinol Lett 19: 111–115

    Article  CAS  Google Scholar 

  54. Brusco LI, Marquez M, Cardinali DP (1998) Monozygotic twins with Alzheimer’s disease treated with melatonin: Case report. J Pineal Res 25: 260–263

    PubMed  CAS  Google Scholar 

  55. Mishima K, Okawa M, Hozumi S, Hishikawa Y (2000) Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian restactivity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons. Chronobiol Int 17: 419–432

    Article  PubMed  CAS  Google Scholar 

  56. Cohen-Mansfield J, Garfinkel D, Lipson S (2000) Melatonin for treatment of sundowning in elderly persons with dementia; a preliminary study. Arch Gerontol Geriatr 31: 65–76

    Article  PubMed  CAS  Google Scholar 

  57. Mahlberg R, Kunz D, Sutej I, Kuhl KP, Hellweg R (2004) Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. J Clin Psychopharmacol 24: 456–459

    Article  PubMed  Google Scholar 

  58. Asayama K, Yamadera H, Ito T, Suzuki H, Kudo Y, Endo S (2003) Double blind study of melatonin effects on the sleep-wake rhythm, Cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch 70: 334–341

    Article  PubMed  Google Scholar 

  59. Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ (2003) A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep 26: 893–901

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Cardinali, D.P., Pandi-Perumal, S.R. (2006). Chronopharmacology and its implications to the pharmacology of sleep. In: Pandi-Perumal, S.R., Monti, J.M. (eds) Clinical Pharmacology of Sleep. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7440-3_13

Download citation

Publish with us

Policies and ethics